<unk>  plc is an American, Irish-domiciled pharmaceutical company that acquires, develops, manufactures and markets brand name drugs and medical devices in the areas of medical aesthetics, eye care, central nervous system, and gastroenterology. The company is the maker of Botox.<unk>  plc was formed in March 2015 when Irish–registered Actavis plc acquired U.S.–registered<unk> , Inc., and assumed the<unk>  name. In 2016,<unk>  sold its generic business, Actavis, to Teva Pharmaceuticals for $40.5 billion. In June 2019, U.S. pharmaceutical company AbbVie announced it had reached an agreement to acquire<unk>  for $63 billion. The merged company would be domiciled in the U.S. for tax purposes.
Allergan
Seratrodast
Dihydroergotamine
Betahistine
Montelukast
Theobromine
Dicycloverine
Pranlukast